GTG — Genetic Technologies Cashflow Statement
0.000.00%
Last trade - 00:00- AU$13.85m
- AU$10.50m
- AU$8.69m
Annual cashflow statement for Genetic Technologies, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 0.297 | 1.04 | 1.33 | 2.4 | 1.96 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -6.07 | -5.71 | -6.3 | -5.66 | -9.72 |
| Capital Expenditures | -0.05 | -0.038 | -0.749 | -0.097 | -0.018 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -0.474 | 0.103 | 0 | -3.36 | -0.294 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.524 | 0.065 | -0.749 | -3.46 | -0.312 |
| Financing Cash Flow Items | -0.431 | -3.3 | -1.97 | -0.01 | -0.916 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 3.13 | 18.4 | 13.7 | -0.279 | 5.92 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -3.36 | 12.1 | 6.69 | -9.17 | -3.88 |